{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:56:36Z","timestamp":1783436196632,"version":"3.54.6"},"reference-count":29,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.04.059","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T10:00:29Z","timestamp":1462701629000},"page":"3427-3433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Development of varicella vaccine in Japan and future prospects"],"prefix":"10.1016","volume":"34","author":[{"given":"Takao","family":"Ozaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshizo","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.04.059_bib0150","series-title":"Vaccines","first-page":"1395","article-title":"Community immunity","author":"Fine","year":"2013"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0160","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199403313301305","article-title":"Outcome after maternal varicella infection in the first 20 weeks of pregnancy","volume":"330","author":"Pastuszak","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0165","first-page":"253","article-title":"Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine","volume":"14","author":"Okuno","year":"1971","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0170","first-page":"235","article-title":"Studies on live rubella vaccine. I. Propagation of rubella virus in developing chick embryos and its laboratory characterization","volume":"11","author":"Okuno","year":"1968","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0175","first-page":"127","article-title":"Studies on live attenuated mumps virus vaccine. II. Biological characteristics of the strains adapted to the amniotic and chorioallantoic cavity of developing chick embryos","volume":"13","author":"Yamanishi","year":"1970","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0180","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(76)92397-7","article-title":"Use of live varicella vaccine in children with acute leukaemia or other malignancies","volume":"24","author":"Hattori","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0190","first-page":"29","article-title":"Application of a live varicella vaccine to hospitalized children and its follow-up study","volume":"25","author":"Katsushima","year":"1982","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0195","first-page":"99","article-title":"Immunization of acute leukemic children with a live varicella vaccine (Oka strain)","volume":"27","author":"Kamiya","year":"1984","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0200","first-page":"69","article-title":"Use of a live varicella vaccine for acute leukemic children shortly after exposure in a children's ward","volume":"21","author":"Ozaki","year":"1978","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0205","series-title":"Requirements for varicella vaccine (live). Requirements for biological substances No. 36","first-page":"102","author":"WHO experts committee on biological standardization","year":"1985"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0091-6749(97)70204-5","article-title":"Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines","volume":"100","author":"Kumagai","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0215","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0264-410X(99)00441-7","article-title":"Gelatin-containing diphtheria\u2013tetanus\u2013pertussis (DTP) vaccine causes sensitization to gelatin in the recipients","volume":"18","author":"Kumagai","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0220","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.vaccine.2004.08.040","article-title":"Safety and immunogenicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan","volume":"23","author":"Ozaki","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0225","doi-asserted-by":"crossref","DOI":"10.11150\/kansenshogakuzasshi.90.291","article-title":"Results of booster vaccination in children with primary vaccine failure after initial varicella vaccination","author":"Ozaki","year":"2016","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0230","first-page":"39","article-title":"Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children","volume":"27","author":"Ozaki","year":"1984","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0235","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/S0264-410X(00)00016-5","article-title":"Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic","volume":"18","author":"Ozaki","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0240","first-page":"400","article-title":"Varicella vaccine","volume":"38","author":"Ozaki","year":"2010","journal-title":"Clin Virol"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0245","first-page":"1490","article-title":"Temperature change and viral titer of varicella vaccine during distribution and storage","volume":"119","author":"Ozaki","year":"2015","journal-title":"J Jpn Pediatr Soc"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0250","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jim.2015.07.011","article-title":"Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-\u03b3 enzyme-linked immunosorbent assay","volume":"426","author":"Hayashida","year":"2015","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0255","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/143.5.684","article-title":"Soluble skin test antigen of varicella-zoster virus prepared from the fluid of infected cultures","volume":"143","author":"Asano","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0260","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.94.4.524","article-title":"Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine","volume":"94","author":"Asano","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0265","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1442-200X.1997.tb03664.x","article-title":"High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain)","volume":"39","author":"Takayama","year":"1997","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0270","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0275","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1016\/j.vaccine.2013.10.060","article-title":"Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program","volume":"31","author":"Ozaki","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0280","first-page":"27","article-title":"Summary of notifiable infectious diseases and conditions \u2013 United States, 2013","volume":"62","author":"CDC.","year":"2015","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.02.058","article-title":"Universal varicella vaccine immunization in Japan","author":"Yoshikawa","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.059_bib0290","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1016\/S0264-410X(03)00303-7","article-title":"Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay","volume":"21","author":"Takahashi","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T16:10:09Z","timestamp":1655741409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16302146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":29,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16302146"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of varicella vaccine in Japan and future prospects","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}